OBJECTIVE: To examine the potential benefits of adding a selective serotonin reuptake inhibitor, sertraline, versus placebo, to trauma-focused cognitive-behavioral therapy (TF-CBT) for improving posttraumatic stress disorder and related psychological symptoms in children who have experienced sexual abuse. METHOD: Twenty-four10- to 17-year-old female children and adolescents and their primary caretakers were randomly assigned to receive TF-CBT + sertraline or TF-CBT + placebo for 12 weeks. RESULTS: Both groups experienced significant improvement in posttraumatic stress disorder and other clinical outcomes from pre- to posttreatment with no significant group x time differences between groups except in Child Global Assessment Scale ratings, which favored the TF-CBT + sertraline group. CONCLUSIONS: Only minimal evidence suggests a benefit to adding sertraline to TF-CBT. A drawback of adding sertraline was determining whether TF-CBT or sertraline caused clinical improvement for children with comorbid depression. Current evidence therefore supports an initial trial of TF-CBT or other evidence-supported psychotherapy for most children with PTSD symptoms before adding medication.
RCT Entities:
OBJECTIVE: To examine the potential benefits of adding a selective serotonin reuptake inhibitor, sertraline, versus placebo, to trauma-focused cognitive-behavioral therapy (TF-CBT) for improving posttraumatic stress disorder and related psychological symptoms in children who have experienced sexual abuse. METHOD: Twenty-four 10- to 17-year-old female children and adolescents and their primary caretakers were randomly assigned to receive TF-CBT + sertraline or TF-CBT + placebo for 12 weeks. RESULTS: Both groups experienced significant improvement in posttraumatic stress disorder and other clinical outcomes from pre- to posttreatment with no significant group x time differences between groups except in Child Global Assessment Scale ratings, which favored the TF-CBT + sertraline group. CONCLUSIONS: Only minimal evidence suggests a benefit to adding sertraline to TF-CBT. A drawback of adding sertraline was determining whether TF-CBT or sertraline caused clinical improvement for children with comorbid depression. Current evidence therefore supports an initial trial of TF-CBT or other evidence-supported psychotherapy for most children with PTSD symptoms before adding medication.
Authors: Margaret T Anton; Leigh E Ridings; Rochelle Hanson; Tatiana Davidson; Benjamin Saunders; Matthew Price; Carla Kmett Danielson; Brian Chu; Clara E Dismuke; Zachary W Adams; Kenneth J Ruggiero Journal: Contemp Clin Trials Date: 2020-04-19 Impact factor: 2.226
Authors: Briana S Last; Brittany N Rudd; Courtney A Gregor; Hilary E Kratz; Kamilah Jackson; Steven Berkowitz; Arturo Zinny; Lauren P Cliggitt; Danielle R Adams; Lucia M Walsh; Rinad S Beidas Journal: J Community Psychol Date: 2019-12-24
Authors: Jennifer B Dwyer; Argyris Stringaris; David A Brent; Michael H Bloch Journal: J Child Psychol Psychiatry Date: 2020-02-04 Impact factor: 8.982
Authors: Shannon Dorsey; Katie A McLaughlin; Suzanne E U Kerns; Julie P Harrison; Hilary K Lambert; Ernestine C Briggs; Julia Revillion Cox; Lisa Amaya-Jackson Journal: J Clin Child Adolesc Psychol Date: 2016-10-19
Authors: Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker Journal: BMC Psychiatry Date: 2014-07-02 Impact factor: 3.630
Authors: Rinad S Beidas; Danielle R Adams; Hilary E Kratz; Kamilah Jackson; Steven Berkowitz; Arturo Zinny; Lauren Pilar Cliggitt; Kathryn L DeWitt; Laura Skriner; Arthur Evans Journal: Eval Program Plann Date: 2016-07-27